Friday, May 16, 2025 | 04:53 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Norris Medicines Share Price

Know More
BSENSE

16.48 0.06 (0.37%)

04:01 PM, 16-May-2025
Stock not traded

BSE : 524414

Sector : Health care

ISIN Code : INE744C01029

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 16-May-2025 | 04:01 PM IST

Market Cap (₹ Cr)

16

Traded Value (₹ Cr)

0.00

Volume (Shares)

2,117

Face Value (₹)

10

52-Week High (₹)

27.74

52-Week High Date

14-Nov-2024

52-Week Low (₹)

10.70

52-Week Low Date

15-May-2024

All Time High (₹)

36.75

All Time High Date

14-Feb-2022

All Time Low (₹)

0.60

All Time Low Date

07-Jul-1998

Norris Medicines Ltd

Norris Medicines Limited was established in September 1990 as a small scale unit at GIDC Estate Ankleshwar to manufacture non sterile dosage e.g. tablets capsules Liquid Orals Copical ointments. The Company was subsequently converted into Public Limited Company on March 7 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules & V...
Read More
BSE
NSE

Norris Medicines Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Norris Medicines Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230GJ1990PLC086581</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>18.59</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: PRIYANKA LOHIYA <br/> Designation: Compliance Officer <br/> EmailId: cspriyankalohiya@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Iqubal Patel <br/> Designation: Chief Financial Officer <br/> EmailId: norrismedicines@gmail.com</div> </div> <div> <br/> Date: 29/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

More

Norris Medicines Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

16

EPS - TTM (₹) [S]

0.00

P/E Ratio (X) [S]

-

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]-14.28
P/B Ratio (₹) [S]-1.15

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Data Not Found

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

16.12

17.50

Week Low/High (₹)

15.35

18.00

Month Low/High (₹)

14.81

20.00

Year Low/High (₹)

10.70

28.00

All time Low/High (₹)

0.60

37.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-3.06%-3.62%4.21%
1 Month-7.93%-6.86%6.75%
3 Month-21.52%-8.42%9.12%
6 Month-34.34%-6.12%6.32%
1 Year51.19%-11.77%11.68%
3 Year-36.12%-55.42%57.93%

Company Info

Company Information

Managing Director : Vimal D Shah

Non Executive Director : Praveen Bafna

Independent Director : Angamuthu Vadivel

Company Sec. & Compli. Officer : Priyanka Lohiya

Additional Director : VENKATACHALAM SATHYA

Registered Office: Plot No 801/P & 802, GIDC Industrial Estate,Ankleshwar,Gujarat-393002 Ph: 91-2646-223462/227530

Email:norrismedicines@gmail.com; contact@norrispharma.co

URL:http://www.norrispharma.com

FAQs about Norris Medicines Ltd

1. What's the Norris Medicines Ltd share price today?
Norris Medicines Ltd share price was Rs 16.48 at 04:01 PM IST on 16th May 2025. Norris Medicines Ltd share price was up by 0.37% over the previous closing price of Rs 16.42. Norris Medicines Ltd share price trend:

  • Last 1 Month: Norris Medicines Ltd share price moved down by 7.93% on BSE.
  • Last 3 Months: Norris Medicines Ltd share price moved down by 21.52% on BSE.
  • Last 12 Months: Norris Medicines Ltd share price moved up by 51.19% on BSE.
  • Last 3 Years: Norris Medicines Ltd share price moved down by 36.12% on BSE.


2. How can I quickly analyse the performance of the Norris Medicines Ltd stock?
The performance of the Norris Medicines Ltd stock can be quickly analysed on the following metrics:

  • Price to book value ratio is -1.15


3. What is the market cap of Norris Medicines Ltd?
Norris Medicines Ltd has a market capitalisation of Rs 16 crore.


4. What is Norris Medicines Ltd's 52-week high/low share price?
The Norris Medicines Ltd’s 52-week high share price is Rs 27.74 and 52-week low share price is Rs 10.70.


6. Which are Norris Medicines Ltd’s peers in the Health care sector?
Norris Medicines Ltd’s top 5 peers in the Health care sector are Chemo Pharma Lab, Desh Rakshak, Parmax Pharma, Norris Medicines, Venmax Drugs, Decipher Labs, Unjha Formul..


7. Who owns how much in Norris Medicines Ltd?
Key changes to the Norris Medicines Ltd shareholding are as follows:

  • Promoter holding in Norris Medicines Ltd has gone down to 34.00 per cent as of Mar 2025 from 34.01 per cent as of Jun 2024.